GR1010683B - Συνθεση για την ενισχυση της φυσιολογικης λειτουργιας του θυροειδους - Google Patents

Συνθεση για την ενισχυση της φυσιολογικης λειτουργιας του θυροειδους Download PDF

Info

Publication number
GR1010683B
GR1010683B GR20230100259A GR20230100259A GR1010683B GR 1010683 B GR1010683 B GR 1010683B GR 20230100259 A GR20230100259 A GR 20230100259A GR 20230100259 A GR20230100259 A GR 20230100259A GR 1010683 B GR1010683 B GR 1010683B
Authority
GR
Greece
Prior art keywords
strengthening
composition
thyroid function
physiological
physiological thyroid
Prior art date
Application number
GR20230100259A
Other languages
English (en)
Inventor
Ιουλια Κλεωνος Τσετη
Original Assignee
Ιουλια Κλεωνος Τσετη
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ιουλια Κλεωνος Τσετη filed Critical Ιουλια Κλεωνος Τσετη
Priority to GR20230100259A priority Critical patent/GR1010683B/el
Publication of GR1010683B publication Critical patent/GR1010683B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε συνθέσεις για από του στόματος χορήγηση, οι οποίες περιέχουν L-τυροσίνη, εκχύλισμα γαϊδουράγκαθου (Silybum marianum), εκχύλισμα ρίζας ινδικού κερασιού (Ashwagandha),βιταμίνες, μέταλλα και ιχνοστοιχεία, κατάλληλες για την ενίσχυση της φυσιολογικής λειτουργίας του θυροειδούς.
GR20230100259A 2023-03-28 2023-03-28 Συνθεση για την ενισχυση της φυσιολογικης λειτουργιας του θυροειδους GR1010683B (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20230100259A GR1010683B (el) 2023-03-28 2023-03-28 Συνθεση για την ενισχυση της φυσιολογικης λειτουργιας του θυροειδους

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20230100259A GR1010683B (el) 2023-03-28 2023-03-28 Συνθεση για την ενισχυση της φυσιολογικης λειτουργιας του θυροειδους

Publications (1)

Publication Number Publication Date
GR1010683B true GR1010683B (el) 2024-04-29

Family

ID=91582800

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20230100259A GR1010683B (el) 2023-03-28 2023-03-28 Συνθεση για την ενισχυση της φυσιολογικης λειτουργιας του θυροειδους

Country Status (1)

Country Link
GR (1) GR1010683B (el)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060020046A1 (en) * 2002-02-15 2006-01-26 Dms Ip Assets B.V. Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
US20190000930A1 (en) * 2015-02-13 2019-01-03 Eastern Vision Limited Dietary supplements and formulations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060020046A1 (en) * 2002-02-15 2006-01-26 Dms Ip Assets B.V. Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
US20190000930A1 (en) * 2015-02-13 2019-01-03 Eastern Vision Limited Dietary supplements and formulations

Similar Documents

Publication Publication Date Title
MX2020001525A (es) Composiciones de peptido similar al glucagon tipo 1 (glp-1) y sus usos.
MY160412A (en) Oral compositions containing extracts of zingiber officinale and related methods
BRPI0507593A (pt) composições contendo cis-isÈmeros de um composto carotenóide e processo
CO2019001043A2 (es) Composición de cannabis
MY150855A (en) Oral compositions containing extracts of zizyphus joazeiro and related methods
BR112012011294A2 (pt) composição nutritiva para promover o equilíbrio de microbiotas do intestino e a saúde
NZ741022A (en) Flavonoid compositions and methods of use
MY152710A (en) Oral compositions containing extracts of garcinia mangostana l. and related methods
MY150829A (en) Oral compositions containing extracts of myristica fragrans and related methods
MX2013000733A (es) Composiciones de noribogaina.
EA201070893A1 (ru) Способы и композиции для лечения заболеваний костей
MX2022009844A (es) Composiciones y usos del peptido similar al glucagon-1 (glp-1).
JOP20220093A1 (ar) تركيبة صيدلانية تشتمل على سيليكسيباغ
EA201290985A1 (ru) Пероральные ветеринарные фармацевтические и нутрицевтические композиции
BR112021024266A2 (pt) Composições para tratamento bucal sem enxágue
BR112016026667A8 (pt) comprimido oralmente desintegrante para administração de avanafil, métodos associados de fabricação e uso de um inibidor de pde v
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
ZA202107825B (en) Pharmaceutical parenteral composition of dual glp1/2 agonist
EP4248992A3 (en) Foot-and-mouth disease vaccine
EP4400098A3 (en) Co-amorphous forms of beta-lactoglobulin and a drug substance
EA201991951A1 (ru) Низковязкие высококонцентрированные составы на основе эволокумаба и способы их получения
UA75461U (uk) Засіб для профілактики стоматологічних захворювань
MX2017009929A (es) Composiciones y métodos para metabolismo muscular mejorado.
GR1010683B (el) Συνθεση για την ενισχυση της φυσιολογικης λειτουργιας του θυροειδους
AU2018279977A1 (en) Natural and organic binder compositions for oral solid dosage forms

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20240516